Webinar: Showcasing a Scalable Downstream Platform for Multiple AAV Serotypes

Showcasing a Scalable Downstream Platform for Multiple AAV Serotypes

Scientists need a downstream processing platform that can purify a variety of AAV serotypes with consistent recovery and quality to reduce timelines and complexity.

In collaboration with iBET, we’ll show how you can select the right solutions to support scalable and high-performing AAV purification.

What You Will Learn:

Ensure high AAV full capsid recovery from clarification to polishing
Establish a scalable platform for multiple serotypes from PD to manufacturing
Leverage an analytical solution for measuring empty/full capsids and AAV titer

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Complete Form to Watch

André Nascimento

Scientist – Late Stage R&D and Bioproduction Unit, iBET

André Nascimento is a scientist at iBET. He has a master’s degree in biotechnology and a PhD in biotechnology and biosciences. André joined iBET in the late-stage Rr&Dd and bioproduction unit in 2021. Since then, he has focused on upstream and downstream processes of viral vectors, including analytical development. His activities include managing of projects in collaboration with both industry and academia. 

Franziska Bollman

Program Manager for Separation Technologies, Sartorius Stedim Biotech

Dr. Franziska Bollmann is a Program Manager in Separation Technologies at Sartorius, where she manages partnerships for multiple modalities including AAV.

She has years of experience focusing on developing viral vector production processes for gene therapy applications. She is also an experienced project manager, leading global project teams in the biotech industry for more than 10 years.